Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
10.4M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
2.28M
-
Shares change
-
+819K
-
Total reported value, excl. options
-
$20.9M
-
Value change
-
+$8.83M
-
Number of buys
-
26
-
Number of sells
-
-21
-
Price
-
$9.15
Significant Holders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) as of Q1 2025
55 filings reported holding CRVO - CervoMed Inc. - Common Stock, $0.001 par value as of Q1 2025.
CervoMed Inc. - Common Stock, $0.001 par value (CRVO) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.28M shares
of 10.4M outstanding shares and own 22.01% of the company stock.
Largest 10 shareholders include AWM Investment Company, Inc. (863K shares), VANGUARD GROUP INC (379K shares), BlackRock, Inc. (349K shares), MORGAN STANLEY (137K shares), GEODE CAPITAL MANAGEMENT, LLC (116K shares), STATE STREET CORP (112K shares), NORTHERN TRUST CORP (56.7K shares), Nuveen, LLC (34.1K shares), CITIZENS FINANCIAL GROUP INC/RI (26.7K shares), and AVANTAX ADVISORY SERVICES, INC. (26K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.